Open Access
Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
Azzam Hamad
1
,
Gaukhar M. Yusubalieva
2, 3
,
Vladimir P. Baklaushev
2, 3
,
П. М. Чумаков
1
,
Anastasiya V. Lipatova
1
3
Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia
|
Publication type: Journal Article
Publication date: 2023-02-16
PubMed ID:
36851761
Infectious Diseases
Virology
Abstract
Glioblastoma is the most aggressive form of malignant brain tumor. Standard treatment protocols and traditional immunotherapy are poorly effective as they do not significantly increase the long-term survival of glioblastoma patients. Oncolytic viruses (OVs) may be an effective alternative approach. Combining OVs with some modern treatment options may also provide significant benefits for glioblastoma patients. Here we review virotherapy for glioblastomas and describe several OVs and their combination with other therapies. The personalized use of OVs and their combination with other treatment options would become a significant area of research aiming to develop the most effective treatment regimens for glioblastomas.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
7
8
|
|
|
Cancers
8 publications, 9.3%
|
|
|
International Journal of Molecular Sciences
7 publications, 8.14%
|
|
|
Pharmaceutics
3 publications, 3.49%
|
|
|
Frontiers in Immunology
3 publications, 3.49%
|
|
|
Journal for ImmunoTherapy of Cancer
3 publications, 3.49%
|
|
|
Journal of Neuro-Oncology
2 publications, 2.33%
|
|
|
Journal of Translational Medicine
2 publications, 2.33%
|
|
|
Neurological Sciences
2 publications, 2.33%
|
|
|
Cureus
2 publications, 2.33%
|
|
|
Biochemical and Biophysical Research Communications
2 publications, 2.33%
|
|
|
Cells
2 publications, 2.33%
|
|
|
Materials Today Bio
2 publications, 2.33%
|
|
|
Meta-Radiology
1 publication, 1.16%
|
|
|
Toxicology
1 publication, 1.16%
|
|
|
Medical Sciences
1 publication, 1.16%
|
|
|
Virology
1 publication, 1.16%
|
|
|
Biochemical Genetics
1 publication, 1.16%
|
|
|
Oncology Letters
1 publication, 1.16%
|
|
|
BJC Reports
1 publication, 1.16%
|
|
|
Oncologist
1 publication, 1.16%
|
|
|
Journal of Cellular Physiology
1 publication, 1.16%
|
|
|
Journal of NeuroVirology
1 publication, 1.16%
|
|
|
Cancer Immunology, Immunotherapy
1 publication, 1.16%
|
|
|
BioChem
1 publication, 1.16%
|
|
|
Current Treatment Options in Oncology
1 publication, 1.16%
|
|
|
BioNanoScience
1 publication, 1.16%
|
|
|
ACS Nano
1 publication, 1.16%
|
|
|
Neuroscience
1 publication, 1.16%
|
|
|
Molecular Pharmaceutics
1 publication, 1.16%
|
|
|
1
2
3
4
5
6
7
8
|
Publishers
|
5
10
15
20
25
|
|
|
MDPI
25 publications, 29.07%
|
|
|
Springer Nature
24 publications, 27.91%
|
|
|
Elsevier
16 publications, 18.6%
|
|
|
Wiley
4 publications, 4.65%
|
|
|
Frontiers Media S.A.
4 publications, 4.65%
|
|
|
American Chemical Society (ACS)
3 publications, 3.49%
|
|
|
BMJ
3 publications, 3.49%
|
|
|
Spandidos Publications
1 publication, 1.16%
|
|
|
Society for Translational Oncology
1 publication, 1.16%
|
|
|
Pirogov Russian National Research Medical University
1 publication, 1.16%
|
|
|
Bashkir State Medical University
1 publication, 1.16%
|
|
|
Taylor & Francis
1 publication, 1.16%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 1.16%
|
|
|
American Association for Cancer Research (AACR)
1 publication, 1.16%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
86
Total citations:
86
Citations from 2024:
76
(88%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Hamad A. et al. Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies // Viruses. 2023. Vol. 15. No. 2. p. 547.
GOST all authors (up to 50)
Copy
Hamad A., Yusubalieva G. M., Baklaushev V. P., Чумаков П. М., Lipatova A. V. Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies // Viruses. 2023. Vol. 15. No. 2. p. 547.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3390/v15020547
UR - https://www.mdpi.com/1999-4915/15/2/547
TI - Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
T2 - Viruses
AU - Hamad, Azzam
AU - Yusubalieva, Gaukhar M.
AU - Baklaushev, Vladimir P.
AU - Чумаков, П. М.
AU - Lipatova, Anastasiya V.
PY - 2023
DA - 2023/02/16
PB - MDPI
SP - 547
IS - 2
VL - 15
PMID - 36851761
SN - 1999-4915
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2023_Hamad,
author = {Azzam Hamad and Gaukhar M. Yusubalieva and Vladimir P. Baklaushev and П. М. Чумаков and Anastasiya V. Lipatova},
title = {Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies},
journal = {Viruses},
year = {2023},
volume = {15},
publisher = {MDPI},
month = {feb},
url = {https://www.mdpi.com/1999-4915/15/2/547},
number = {2},
pages = {547},
doi = {10.3390/v15020547}
}
Cite this
MLA
Copy
Hamad, Azzam, et al. “Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies.” Viruses, vol. 15, no. 2, Feb. 2023, p. 547. https://www.mdpi.com/1999-4915/15/2/547.
Profiles